đź“ž  +1 (855) 661-4441(US)   đź“ž  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Pericarditis Market Share

ID: MRFR//1315-CR | 156 Pages | Author: Rahul Gotadki| August 2019

The Pericarditis market, focused on addressing inflammation of the pericardium, demands strategic positioning to provide effective treatments. Companies in this market employ diverse strategies to position their products effectively and gain a significant market share.
Companies focus on developing differentiated anti-inflammatory medications tailored specifically for pericarditis. Innovations in drug formulations, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or colchicine, contribute to improved efficacy and patient outcomes, setting products apart in the competitive landscape.
A key strategy is the development of targeted therapeutic approaches catering to different types of pericarditis. Tailoring treatments for idiopathic pericarditis, post-infectious pericarditis, or recurrent pericarditis allows for more precise and effective interventions, attracting healthcare professionals and patients seeking tailored therapeutic options.
Enterprise funding is directed on the newest and precise diagnostic methods to ensure early and accurate detection of pericarditis. Innovations in imaging techniques such as echocardiography or cardiac MRI are graphically displayed and enable us to diagnose at an earlier stage and implement the therapy at the best possible time, increasing its efficacy.
Pericarditis is an important factor in the emotional and physical well-being of patients and, in order to reflect it appropriately, organizations start taking into account a patient-oriented approach. Treatments that ensure quick symptom remedy, little side effects to experience, and simple dosage plan focus on enhanced patient satisfaction, leading to enhanced loyalty hence greater market share.
Enacting dynamic pricing policies is fundamental to a desirable market share improvement. The pharaceutical industry can emphasize their treatment of pericarditis as a cost effective solution that can offer accessible treatments for a wider patient population, or they might present it as a premium option that may differentiate them from the competition.
To develop a wider market share includes entering new locations. `Use the given sentence as a guide, whether by rephrasing the sentence or creating entirely new sentences, to create three different versions of this sentence. Look for opportunities to incorporate new words and phrases, diversify sentence structures, and maintain the overall essence of the sentence. Businesses discover new markets, negotiate complex regulations around the world and develop a powerful brand recognization, as the result of what their overall sales and dominance in the international Pericarditis market are growing.
In this regard, making strong strategic partnerships with Cardiology Centers, Hospitals and Healthcare Instituitions is a significant market positioning strategy we embrace. The collaboration possibility is a good strategy to promote the product with proper distribution, where it is have joint initiatives such as workshops and educational programs and consequently to a broader range on the markets share.

Global Pericarditis Market Overview

The Global Pericarditis Market is expected to reach USD 2381.07 Million by 2030 at 7.30% CAGR during the forecast period 2022-2030

Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms typically include a sudden onset of sharp chest pain. The pain may also be felt in the shoulders, neck, or back. It generally is better sitting up and worse when lying down or breathing deeply.

The increasing prevalence of cardiovascular diseases such as heart attack & hypertension, favorable reimbursement policies, and increasing preference for minimally invasive procedures are the major drivers propelling market growth. However, the side-effects of anti-inflammatory drugs and the risk of bacterial infections constrain the growth of the pericarditis drugs market.

Market Dynamics

The prevalence of cardiovascular diseases is found to be increasing over the last decade. This is attributed to the rising incidences of chronic diseases such as obesity and diabetes, which are major risk factors for cardiovascular diseases such as pericarditis, heart attack, and hypertension. As per the American Heart Association, nearly 92.1 million Americans were diagnosed with cardiovascular diseases in 2017. Additionally, it also stated that the prevalence is found to be higher in men than in women. Furthermore, in the same year, more than 92% of the patients exhibited major symptoms of heart diseases such as chest pain, heartburns, and strokes.

Recently, the prevalence of cardiovascular diseases is found to be increasing from the last few years. The American Heart Association stated that in 2015, 3.7% of the Asian population was diagnosed with chronic heart disease, while 21% of the people had hypertension.

Cardiovascular disease is one of the significant chronic disease responsible for a high death toll across the globe. This emphasizes the need for the development of new diagnostics and treatment devices around the world. The market is also affected by the increasing number of people diagnosed with these diseases at an early stage. Therefore, the prevalence of cardiovascular disease would drive the growth of the market during the forecast period.

The pericarditis drugs market is driven by the increasing number of patients suffering from cardiovascular diseases, thus signifying the need for the development of new technologically advanced devices for monitoring the heart rate. Continuous monitoring of cardiovascular diseases is an important aspect of cardiology. Therefore, the prevalence of pericarditis is increasing with a rise in the prevalence of cardiovascular diseases, fueling market growth.

Global Pericarditis Market Size, by End User, 2017 (USD Million)  Pericarditis Market

Source: MRFR Analysis


The global pericarditis market has been segmented into type, application, and end user. 

Based on type, the global pericarditis drugs market has been segmented acute pericarditis, recurrent pericarditis, and chronic pericarditis.

Based on diagnosis & treatment, the global market has been divided into diagnosis and treatment. The diagnosis segment is further divided into electrocardiogram (ECG), echocardiogram, computerized tomography (CT), X-Ray. The treatment segment is bifurcated into medication (non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine) and surgical treatment.

Based on end user, the global market has been segmented into hospitals & clinics and medical institutes & research laboratories. The hospitals & clinics segment accounted for a market value of USD 840.30 million in 2017.

Key Players

The prominent players in the global pericarditis market are Pfizer Inc., AstraZeneca Plc, Novartis International AG, Allergan plc., and Merck & Co., Inc. are the top five market players in this market. Apart from these, Bayer AG, Reckitt Benckiser Group Plc., PerkinElmer, Inc., FUJIFILM Holdings Corporation, Sanofi, and Johnson & Johnson Services, Inc. are some of the other major players in the global market.

Some of the key strategies followed by the players operating in the global pericarditis market are innovation, product development, acquisition, and expansion.

Asia-Pacific Pericarditis Market Share, by Country, 2017 (%)  Pericarditis Market

Source: MRFR Analysis

Regional Analysis

The global pericarditis market, based on region, is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is estimated to dominate the global pericarditis drugs market during the forecast period. This is attributed to the rising investments in research and development owing to investments in reputed research centers and government institutions and increasing expenditure on healthcare play a vital role in the growth of the regional market. Besides, several research grants are given by governmental agencies.

The European market for pericarditis is expected to be the second-largest during the forecast period. The presence of medical device companies, the rising burden of rheumatoid arthritis (RA), and growing healthcare spending are expected to boost the growth of the market in this region. Additionally, the companies operating in the market are mainly focusing on mergers and acquisition, which is expected to support market growth.

Asia-Pacific is estimated to be the fastest-growing market due to the growing geriatric population, rapid developments in technology. In addition to this, improving healthcare infrastructure has increased the number of research activities in the region. Moreover, in the region, China accounted for a market share of 24.6% in 2017.

Furthermore, the market in the Middle East & Africa is expected to witness slow growth due to limited access to healthcare facilities.

Key Updates

  • In July 2017, Pfizer Inc. extended the collaboration with Catalent, Inc., a global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products for the development and manufacture of Advil Liqui-Gels.

  • In October 2018, Reckitt Benckiser (RB) launched a 24-hour pain relief patch along with a campaign to educate patients about pain to encourage patients to facilitate pain management.

  • In October 2018, FUJIFILM Medical Systems USA, Inc., a provider of diagnostic imaging and medical informatics solutions launched the FCT Embrace wide bore computed tomography (CT) imaging unit in the US, thereby entering into the US computed tomography market.

Market Segmentation

Global Pericarditis Market, by Type

  • Acute Pericarditis

  • Recurrent Pericarditis

  • Chronic Pericarditis

Global Pericarditis Market, by Diagnosis & Treatment

  • Diagnosis

  • Electrocardiogram (ECG),

  • Echocardiogram,

  • Computerized Tomography (CT)

  • X-Ray

  • Treatment

  • Medication

  • Surgical Treatment

Global Pericarditis Market, by End User

  • Hospitals & Clinics

  • Medical Institutes & Research laboratories

Global Pericarditis Market, by Region

  • Americas

    • North America

      • US

      • Canada

    • Latin America

  • Europe

    • Western Europe

      • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe

    • Eastern Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • Middle East & Africa

    • Middle East

    • Africa

Available Additional Customizations

  • Pricing Analysis

  • Competitive Benchmarking for Global Pericarditis Market

Intended Audience

  • Medical device manufacturers and distributors

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies

  • Pharmaceutical companies

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.